J. Adeva's Profile

Role	Title	Level	Year	L/R
🐜	Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. 26 auth. G. Abou-Alfa, T. Macarulla, M. Javle, R. Kelley, S. Lubner, J. Adeva, J. Cleary, D. Catenacci, M. Borad, J. Bridgewater, W. Harris, A. Murphy, D. Oh, J. Whisenant, M. Lowery, ... L. Goyal, R. Shroff, A. El-Khoueiry, Bin Fan, Bin Wu, Christina X. Chamberlain, Liewen Jiang, C. Gliser, S. Pandya, J. Valle, A. Zhu	9	2020	9 🐜
🐜	Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation 27 auth. A. Zhu, T. Macarulla, M. Javle, R. Kelley, S. Lubner, J. Adeva, J. Cleary, D. Catenacci, M. Borad, J. Bridgewater, W. Harris, A. Murphy, D. Oh, J. Whisenant, M. Lowery, ... L. Goyal, R. Shroff, A. El-Khoueiry, Christina X. Chamberlain, E. Aguado-Fraile, S. Choe, Bin Wu, Hua Liu, C. Gliser, S. Pandya, J. Valle, G. Abou-Alfa	8	2021	8 🐜
🐜	Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. 44 auth. L. Izquierdo-Sánchez, A. Lamarca, A. La Casta, S. Buettner, K. Utpatel, H. Klümpen, J. Adeva, A. Vogel, A. Lleo, L. Fabris, M. Ponz-Sarvisé, R. Brustia, V. Cardinale, C. Braconi, G. Vidili, ... N. Jamieson, R. Macias, J. P. Jonas, M. Marzioni, W. Hołówko, T. Folseraas, J. Kupčinskas, Z. Spârchez, M. Krawczyk, Ł. Krupa, V. Scripcariu, G. Grazi, A. Landa-Magdalena, J. Ijzermans, K. Evert, J. Erdmann, F. López-López, A. Saborowski, Alexander Scheiter, A. Santos-Laso, G. Carpino, J. Andersen, J. Marin, D. Alvaro, L. Bujanda, A. Forner, J. Valle, B. Koerkamp, J. Banales	7	2021	7 🐜
🦁	Medical treatment for cholangiocarcinoma 9 auth. J. Adeva, B. Sangro, M. Salati, J. Edeline, A. La Casta, A. Bittoni, ... R. Berardi, J. Bruix, J. Valle	6	2019	6 🦁
🐜	Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study 13 auth. Mónica P. Cala, M. T. Agulló-Ortuño, Elena Prieto-García, C. González-Riaño, L. Parrilla-Rubio, C. Barbas, C. V. Díaz-García, Antonia García, C. Pernaut, J. Adeva, ... M. C. Riesco, F. J. Rupérez, J. López-Martín	6	2018	6 🐜
🐜	Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System 18 auth. A. Lamarca, A. Santos-Laso, K. Utpatel, A. La Casta, S. Stock, A. Forner, J. Adeva, T. Folseraas, L. Fabris, R. Macias, ... M. Krawczyk, M. Krawczyk, V. Cardinale, C. Braconi, D. Alvaro, M. Evert, J. Banales, J. Valle	5	2020	5 🐜
🐜	Final results from ClarIDHy, a global, phase III, randomized, double-blind study of ivosidenib (IVO) versus placebo (PBO) in patients (pts) with previously treated cholangiocarcinoma (CCA) and an isocitrate dehydrogenase 1 (IDH1) mutation. 20 auth. A. Zhu, T. Macarulla, M. Javle, R. Kelley, S. Lubner, J. Adeva, J. Cleary, D. Catenacci, M. Borad, J. Bridgewater, ... W. Harris, A. Murphy, D. Oh, J. Whisenant, Bin Wu, Liewen Jiang, C. Gliser, S. Pandya, J. Valle, G. Abou-Alfa	5	2021	5 🐜
🐜	Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study. 25 auth. J. Valle, A. Vogel, C. Denlinger, A. He, L. Bai, R. Orlova, E. Van Cutsem, J. Adeva, Li‐Tzong Chen, R. Obermannova, T. Ettrich, Jen‐Shi Chen, H. Wasan, A. Girvan, Wei Zhang, ... Jiangang Liu, Chunlao Tang, P. Ebert, A. Aggarwal, S. Mcneely, B. Moser, Joana M. Oliveira, R. Carlesi, R. Walgren, D. Oh	5	2021	5 🐜
🐜	Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain 38 auth. M. Hidalgo, R. Álvarez, J. Gallego, C. Guillén-Ponce, B. Laquente, T. Macarulla, A. Munoz, M. Salgado, R. Vera, J. Adeva, I. Alés, S. Arévalo, J. Blázquez, À. Calsina, A. Carmona, ... E. Madaria, R. Díaz, L. Díez, T. Fernández, B. G. D. Paredes, M. Gallardo, I. González, O. Hernando, P. Jiménez, A. López, C. Lopez, F. López-Rios, Elena Escalera Martín, J. Martínez, Alfonso Martínez, J. Montáns, R. Pazo, J. C. Plaza, I. Peiró, J. Reina, A. Sanjuánbenito, R. Yayá, A. Carrato	4	2016	4 🐜
🐜	Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study 26 auth. Ana Fernández, M. Salgado, A. García, E. Buxó, R. Vera, J. Adeva, P. Jiménez-Fonseca, G. Quintero, C. Llorca, M. Cañabate, L. López, A. Muñoz, P. Ramírez, P. Gonzalez, C. Lopez, ... M. Reboredo, E. Gallardo, M. Sánchez-Cánovas, J. Gallego, C. Guillén, Nuria Ruiz-Miravet, Víctor Navarro-Pérez, J. De la camara, I. Alés-Díaz, R. Pazo-Cid, A. Carmona-Bayonas	4	2018	4 🐜